Market revenue in 2023 | USD 97.9 million |
Market revenue in 2030 | USD 158.4 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.33% in 2023. Horizon Databook has segmented the Spain clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Due to rising number of clinical trials, the demand for clinical trial supply and logistics is expected to grow at a significant rate in the region.
Clinical trials in early stages are growing rapidly in Spain due to high scientific level of professionals in Spanish National Health Systems & commitment of pharmaceutical firms to R&D.
Clinical trials in early stages accounted for 51.4% of the total market. This is largely due to the new Royal Decree of Clinical Trials, which came into effect in 2016 and created a much more favorable environment for R&D of new medicines.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Spain clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account